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Abstract
Background: Women with non-ST elevation myocardial infarction (NSTEMI) have similar extent of myo-
cardial ischemia but less obstructive coronary artery disease (CAD) than their male counterparts. We tested the
impact of global coronary artery plaque area and artery tortuosity on myocardial perfusion in NSTEMI patients.
Methods: Coronary artery plaque area was determined by quantitative angiography in 108 patients (32%
women) with NSTEMI. Myocardial perfusion was assessed by contrast echocardiography in the 17 individual
left ventricular segments. Artery tortuosity was defined as ‡ 3 curves > 45 in a main coronary artery.
Results: Age, prevalence of hypertension, and diabetes did not differ between sexes (all nonsignificant).
Women had lower prevalence of ‡ 50% coronary artery stenosis (74% vs. 91%, p< 0.05), while global coronary
plaque area (35– 22 vs. 43 – 21mm2) and the number of segments with hypoperfusion (6.9– 3.7 vs. 7.2– 3.4)
did not differ between sexes (both p> 0.07). In multivariate analysis, larger coronary artery plaque area was
associated with a 35% higher risk for having severe myocardial hypoperfusion (odds ratio 1.35 [95% confidence
interval 1.01–1.80], p < 0.05) in the total study population, while no association between artery tortuosity and
myocardial ischemia was found. Similar results were obtained in separate analysis among women and men.
Conclusion: In women and men with NSTEMI, the global coronary artery plaque area was an important
determinant of the severity of myocardial hypoperfusion at rest independent of presence of significant coronary
stenoses. These findings may expand current understanding of NSTEMI in patients with nonobstructive CAD.
Introduction
Sex differences in coronary artery disease (CAD) path-ophysiology have previously been demonstrated both in
autopsy-based and clinical studies,1–3 including differences
in coronary artery plaque composition and distribution as
well as coronary artery tortuosity.4–9 In particular, non-
obstructive CAD on angiography is found more often in
women compared to men, irrespective of clinical presenta-
tion of the coronary artery disease.5
Previous studies using contrast echocardiography or cardiac
magnetic resonance imaging have demonstrated that ischemic
burden measured by these techniques is an important prog-
nosticator in particular in women with nonobstructive
CAD.10,11 In a smaller study,we recently demonstrated that the
extent of myocardial hypoperfusion in patients with non-ST
elevation myocardial infarction (NSTEMI) was comparable in
women and men despite less obstructive CAD in women.7
However, it is not clear whether coronary artery plaque area
may influence myocardial perfusion in NSTEMI patients in-
dependent of presence of significant coronary artery stenoses.
Furthermore, others have suggested that also artery tortuosity
may influence coronary perfusion.9 The aim of this study was
therefore to explore if coronary plaque area and arterial tortu-
osity impacted myocardial perfusion in NSTEMI patients, and
thereby could explain the mismatch between extent of myo-
cardial hypoperfusion and presence of significant CAD previ-
ous reported in NSTEMI women.
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Materials and Methods
Study population
A total of 126 consecutive patients diagnosed with acute
NSTEMI, defined as the combination of chest pain and tro-
ponin T elevation, hospitalized at the Department of Heart
Disease, HaukelandUniversity Hospital, fromMarch through
December 2008 and scheduled for acute coronary angiogra-
phy within 72 hours after admittance were eligible for the
study. Excluding patients with hemodynamically unstable
disease, mechanical valve prostheses or severe pulmonary
disease, a total of 110 patients signed informed consent and all
of them underwent myocardial contrast echocardiography
prior to scheduled coronary angiography.12
For the present post-hoc analysis, reanalyzing the angio-
grams in this previous series with quantitative coronary an-
giography, two of the 110 patients were excluded because all
native coronary arteries were occluded, leaving 108 patients
for the present study population. Clinical risk assessment was
performed in all patients using the thrombolysis in myocar-
dial infarction (TIMI) risk score model.13 The study was
approved by the regional ethical committee and performed in
accordance with the Helsinki declaration.
Quantitative coronary angiography
Quantitative coronary angiography was performed offline
by a single reader (IE) blinded to clinical data and myocardial
perfusion assessment using a digitalized automatic edge de-
tecting analysis software (QAngio XA 7.1, MEDIS Medical
Imaging Systems, Leiden, The Netherlands) (Fig. 1, panel A).
The coronary artery tree was divided into 17 segments,
following the modified American Heart Association model.14
The tip of the catheter was used for calibration. Stenosis
severity and plaque area assessed as lumen diameter reduc-
tion was determined in all vessel segments with a diameter
> 1.5mm. Global coronary artery plaque area was calculated
as the sum of plaque area in all segments. A coronary artery
lumen diameter reduction of ‡ 50 % on the angiogram was
considered a significant stenosis.
Coronary artery tortuosity was measured in the three main
coronary arteries in standardized views: The left anterior
descending artery in the right anterior oblique view with
cranial angulation, the left circumflex artery in the left an-
terior oblique with caudal angulation and the right coronary
artery in the right anterior oblique view.9 Coronary tortuosity
was regarded present if ‡ 3 curves > 45 was found in the
same artery (Fig. 1, panel B).
Echocardiography
Quantitative echocardiography was performed following
the joint European Association of Echocardiography and
American Society of Echocardiography guidelines.15 Left
ventricular (LV) ejection fraction was assessed by the mod-
ified biplane Simpson formula and regional LV function by
wall motion scoring.15 Wall motion score was assessed in
apical 2-, 3-, and 4-chamber views using a 17-segment LV
model as recommended in current quantitation guidelines.15
The average wall motion score value was taken as wall motion
score index in the individual patients. Methods and results
from myocardial contrast echocardiography have previously
been reported in details.7,12 In short, myocardial contrast
echocardiography was performed at rest by real-time low-
mechanical index imaging and destruction–replenishment us-
ing Cadance Contrast Pulse Sequencing technology (Acuson
Sequoia C512, Siemens, Mountain View, CA, echocardio-
graph). An intravenous bolus dosage of 0.3mL Perflutren Li-
pid Microsphere ultrasound contrast (Luminity, Lantheus
Medical Imaging, North Billerica, MA) was given before
perfusion imaging. The bolus dosagewas repeated if necessary
to ensure a stable contrast concentration and avoid contrast
swirling during image acquisition. Regional myocardial per-
fusion was scored visually as normal (contrast replenishment
within five heart beats) or hypoperfusion (delayed contrast
replenishment after more than five heart beats) using the
guideline-recommended 17 segment LV model (Fig. 2).15,16
The extent ofmyocardial perfusion abnormalities was assessed
as the number of segments with hypoperfusion. Severe myo-
cardial hypoperfusionwas considered present if hypoperfusion
was detected in ‡ 6 LV segments.12
Statistics
Data management and statistical analysis were performed
by the IBM SPSS statistical program version 20.0 (IBM
SPSS, Chicago, IL). The study had 80% power to detect a
30% difference in coronary artery stenosis between women
andmen at a statistical level of 0.05. Continuous variables are
reported as mean and standard deviation and categorical
variables as numbers and percentages. Comparisons between
groups were performed by unpaired t-test or chi-squared
FIG. 1. Quantitative coronary
angiography. Coronary artery pla-
que area (A) and coronary artery
tortuosity (B) assessed in the left
anterior descending artery.
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statistics as appropriate. Covariates of global coronary artery
plaque area and tortuosity were identified by Pearson’s cor-
relation coefficient and logistic regression analysis as ap-
propriate. Independent covariates of the extent of myocardial
hypoperfusion were identified in multiple linear regression
analysis. Covariates of severe hypoperfusion (involving ‡ 6
LV segments) were identified in multiple logistic regression
analysis. The associations of presence of severe myocardial
hypoperfusion with global coronary artery plaque area and
presence of significant coronary artery stenosis were tested in
receiver operator characteristics curve analysis. A p value
< 0.05 was considered statistical significant. The intraob-
server variability of myocardial perfusion assessment and of
coronary artery plaque area measurement was calculated
separately from echocardiographic and angiographic images,
respectively, in 11 patients analyzed twice and reported as
intraclass correlation coefficient.
Results
Patient characteristics
The proportion of patients > 65 years of age was signifi-
cantly higher amongwomen, whilemean age, troponinT levels
and TIMI risk score did not differ between women and men
(Table 1). There were no sex differences in anti-ischemic
treatment at study entrance. None of the women were on hor-
mone replacement therapy. The extent of wall motion abnor-
malities and myocardial hypoperfusion did not differ between
women and men, reflecting comparable myocardial infarct size
(Table 2). The mean time between contrast echocardiography
and angiographywas 1.87– 2.6 days, with a median of 1.0 day.
There were no adverse events from contrast infusions, except
for three patients who experienced transient lower back pain.
Coronary artery plaque area
A total of 35 main arteries had proximal total occlusion.
From the total of 1422 coronary artery segments visible on
the angiograms, 69 segments were excluded from analysis
due to poor image quality and vessel overlap, and another 170
segments were excluded due to luminal diameter £ 1.5mm,
which cannot be analyzed with our method, leaving a total of
1252 (88% of visible segments on the angiogram) for as-
sessment of coronary artery plaque area.
Reproducibility of myocardial perfusion score by in-
traclass correlation coefficient was 0.95 (95% confidence
FIG. 2. Myocardial contrast echo-
cardiography. Apical 4-chamber, 2-
chamber and long axis view images
taken five beats post flash demon-
strating subendocardial and trans-
mural hypoperfusion in the apical
left ventricular segments marked
with green arrows.
Table 1. Clinical Characteristics of the Total Study Population and Groups of Women and Men
Total Women Men
(n = 108) (n = 34) (n = 74) p
Age (years) 67 – 12 70 – 12 66– 12 0.160
Age > 65 years (%) 56.5 70.6 50.0 0.045
BMI (kg/m2) 27– 5 27– 5 27 – 4 0.973
Systolic blood pressure (mmHg) 150– 24 150– 22 150 – 25 0.906
Diastolic blood pressure (mmHg) 85 – 13 85 – 13 85– 13 0.917
TIMI risk score 3.24 – 1.41 3.47 – 1.44 3.14 – 1.39 0.252
Family history of premature CAD (%) 40 41 39 0.854
Hypertension (%) 44 44 43 0.932
Hypercholesterolemia (%) 49 65 42 0.028
Diabetes mellitus (%) 19 21 19 0.839
Current smoker (%) 28 15 34 0.040
Peak troponin T level (ng/L) 680– 1170 530– 660 750 – 1300 0.353
Previous myocardial infarction (%) 29 29 29 0.912
Betablocker use (%) 33 32 34 0.884
Calcium channel blockers use (%) 11 9 12 0.608
Statin use (%) 41 32 45 0.229
Acetylsalicylic acid use (%) 42 47 39 0.441
BMI, body mass index; CAD, coronary artery disease; TIMI, thrombolysis in myocardial infarction risk score.
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interval [CI] 0.90–0.98) and for coronary artery plaque area
0.86 (95% CI 0.75–0.91).
Global coronary artery plaque area did not differ signifi-
cantly between women and men despite lower prevalence of
significant coronary artery stenoses and multivessel disease
in women (Table 2). In receiver operating characteristic
curve analysis, global coronary artery plaque area was sig-
nificantly associated with having severe myocardial hypo-
perfusion in both women and men, while presence of
significant coronary artery stenosis was significantly
Table 2. Echocardiographic and Angiographic Findings in the Total Study
Population and Separately in Women and Men
Total Women Men
(n = 108) (n = 34) (n = 74) p
LV end-diastolic diameter (cm) 5.09 – 0.65 4.76 – 0.56 5.25 – 0.65 < 0.001
LV end-systolic diameter (cm) 3.65 – 0.73 3.36 – 0.64 3.79 – 0.73 0.004
Intraventricular septum thickness (cm) 1.20 – 0.18 1.12 – 0.20 1.21 – 0.17 0.737
Posterior wall thickness (cm) 1.02 – 0.13 0.99 – 0.12 1.03 – 0.13 0.140
LV ejection fraction (%) 56 – 12 58 – 12 54– 11 0.165
Extent of wall motion abnormality (segments) 3.6 – 3.7 3.7 – 4.1 3.6 – 3.5 0.893
Extent of hypoperfusion (segments) 7.1 – 3.5 6.9 – 3.7 7.2 – 3.4 0.747
Severe hypoperfusion (%) 63.9 64.7 63.5 0.905
Significant stenosis (%) 85 74 91 0.021
Total coronary artery occlusion (%) 34 35 34 0.878
Wall motion score index 1.22 – 0.23 1.23 – 0.26 1.22 – 0.23 0.880
Multivessel disease (%) 49 35 55 0.052
Coronary artery tortuosity (%) 68 82 61 0.026
Coronary artery plaque area (mm2) 41 – 22 35 – 22 43– 21 0.071
LV, left ventricular.
FIG. 3. Global coronary artery plaque area and severe myocardial hypoperfusion. Receiver operating curve analysis of the
univariate association of presence of severe myocardial hypoperfusion with global coronary plaque area and presence of
significant coronary artery stenosis in women and men.
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associated with severe myocardial hypoperfusion only in
women, probably reflecting the low prevalence of non-
obstructive CAD in men (Fig. 3).
Coronary artery tortuosity
A total of 273 native main coronary arteries were visible on
the coronary angiograms. Of these, 34 were excluded due to
low image quality, leaving 239 (88%) available for analysis of
tortuosity. All three main coronary arteries could be assessed in
65 patients, two in 31 patients, and one in 7 patients. Tortuosity
was more prevalent among women than men (Table 3). Global
coronary artery plaque area did not differ between patients with
tortuous and non-tortuous coronary arteries (42.0– 23.5 vs.
38.0– 17.4mm2, p= 0.367). Tortuosity was not associatedwith
the extent of myocardial hypoperfusion in the total study
population or in men and women analyzed separately.
Determinants of myocardial hypoperfusion
A significant association was found between global coro-
nary plaque area and both severity and extent of myocardial
hypoperfusion in univariate analyses (both p < 0.05) (Tables
3, 4). In multiple logistic regression analysis, adjusting for
known confounders of hypoperfusion, a 10mm2 higher glo-
bal plaque area was associated with a 35% higher risk for
having severe myocardial hypoperfusion on the echocardio-
gram (odds ratio 1.35; 95% CI 1.01–1.80, p = 0.047), inde-
pendent of presence of significant coronary artery stenosis
(Table 3). However, the association of larger global coronary
plaque area with larger extent of myocardial hypoperfusion
was attenuated and became borderline statistically significant
when adjusted for confounders in multivariate analysis
(b= 0.18, p = 0.057) (Table 4).
Discussion
The present study demonstrates that global coronary artery
plaque area is an important determinant of the severity of
myocardial hypoperfusion in NSTEMI patients, indepen-
dent of presence of significant coronary artery stenoses.
Of note, global coronary artery plaque area did not differ
between sexes despite lower prevalence of obstructive CAD
in women. In fact, nonobstructive CAD was nearly 3-fold
more prevalent in women than in men in the present study,
in accordance with previous reports from registries and
meta-analyses.5,6 Although computer tomography coronary
angiography is recognized as a superior method for assess-
ment of coronary artery plaque area, invasive coronary an-
giography is the preferred diagnostic technique for diagnosis
of CAD in current management guidelines for NSTEMI pa-
tients.17 Therefore, our findings are relevant for clinical practice.
Distinct sex differences in coronary atherosclerosis are
well described.2 Typically, women have more diffuse ath-
erosclerosis, smaller arteries and more microvascular in-
volvement.2,18 These factors may contribute to the reported
sex difference in treatment procedures and outcome among
CAD patients.19,20 Intravascular ultrasound in women with
Table 3. Predictors of Severe Myocardial Hypoperfusion ( ‡ 6 LV Myocardial Segments)
Identified in Univariate and Multivariate Logistic Regression Analyses
Univariate analysis Multivariate analysis
Independent variable OR 95% CI p OR 95% CI p
Global coronary plaque area (per 10mm2) 1.32 (1.05–1.66) 0.019 1.35 (1.01–1.80) 0.047
Significant stenosis 5.03 (1.60–15.83) 0.006 5.14 (1.29–20.54) 0.021
Age > 65 years 3.82 (1.67–8.73) 0.002 3.99 (1.51–10.55) 0.005
Female sex 1.05 (0.45–2.46) 0.905 1.72 (0.57–5.23) 0.339
Coronary tortuosity 0.50 (0.27–1.21) 0.123 0.49 (0.17–1.37) 0.173
Hypertension 0.61 (0.28–1.35) 0.22 0.51 (0.20–1.34) 0.173
Diabetes mellitus 0.70 (0.27–1.85) 0.48 0.47 (0.14–1.54) 0.213
Hypercholesterolemia 0.87 (0.40–1.91) 0.73 0.70 (0.26–1.86) 0.473
95% CI, 95% confidence interval; OR, odds ratio.
Table 4. Independent Covariates of the Extent of LV Myocardial Hypoperfusion
in Multivariate Linear Regression Analysis (Multiple R2 = 0.28, p < 0.01)
Univariate analysis Multivariate analysis
Independent variable Beta coefficient p Beta coefficient p Tolerance VIF
Global coronary plaque area (mm2) 0.27 0.005 0.18 0.057 0.852 1.173
Age > 65 years 0.34 < 0.001 0.28 0.003 0.885 1.130
Significant stenosis 0.37 < 0.001 0.31 0.001 0.836 1.196
Coronary tortuosity - 0.16 0.094 - 0.12 0.191 0.886 1.128
Female sex - 0.03 0.747 - 0.06 0.523 0.799 1.251
Hypertension - 0.03 0.792 - 0.05 0.616 0.905 1.105
Diabetes mellitus 0.02 0.843 - 0.03 0.714 0.861 1.161
Hypercholesterolemia - 0.03 0.726 - 0.10 0.308 0.841 1.189
VIF, variance inflation factor.
CORONARY ARTERY PLAQUE AREA AND HYPOPERFUSION 371
chest pain and nonobstructive CAD has demonstrated a high
prevalence of atherosclerosis with positive remodeling and
preserved lumen size.21,22 This emphasizes the limitation of
the present study using angiography to estimate the coronary
artery plaque area, since only the luminal narrowing is vi-
sualized on the angiogram. In addition, it was not possible to
measure plaque area in coronary arteries < 1.5mm in diam-
eter with our method. Consequently, global coronary artery
plaque area may have been underestimated, in particular in
women in our study, due to the combination of more positive
remodeling and smaller coronary artery diameter. Further-
more, angiographic normal reference segments often contain
mild to moderate diffuse atherosclerosis, possibly leading
to an underestimation of the true lumen diameter, and thereby
of the plaque area.23 Still, as demonstrated, reproducibility
of global coronary plaque area measurement by our method
was good.
The prognostic importance of the ischemic burden as-
sessed by contrast echocardiography at rest has been docu-
mented in patients with acute chest pain.11,24 The use of
contrast stress echocardiography in assessment of CAD risk
in menopausal women is currently under evaluation.25 In
patients with myocardial infarction, larger extent of myo-
cardial hypoperfusion by contrast echocardiography at rest
has been demonstrated to predict unfavorable LV remodel-
ing and impaired prognosis.24,26 Similarly, previous studies
assessing myocardial perfusion by magnetic resonance im-
aging have reported increased morbidity, in particular hos-
pitalizations for angina pectoris, in women with chest pain
and nonobstructive CAD.10,27 Consequently, extent and se-
verity of the perfusion abnormalities are important prog-
nosticators in patients with different types of acute coronary
syndromes.
It was recently demonstrated in a numerical simulation
study that coronary artery tortuosity may induce myocardial
ischemia through a reduction in coronary artery perfusion
pressure.28 Typically, coronary artery tortuosity is more
prevalent in women and in patients with hypertension.9 In
this study, tortuosity was indeed more prevalent in women,
but not associated with hypertension. Coronary artery tor-
tuosity was not associated with myocardial hypoperfusion
at rest neither in women nor men. Thus, the clinical rele-
vance of coronary tortuosity in NSTEMI remains to be
established.
Finally, endothelial dysfunction, vessel inflammation and
microvascular disease may all contribute to myocardial hy-
poperfusion in NSTEMI patients with nonobstructive CAD
beyond the global coronary artery plaque area.2,29,30 How-
ever, these factors were not measured in the present study. On
the other hand, hypertension and diabetes, comorbidities
known to be associated with endothelial dysfunction did not
differ between women and men, and also did not predict the
extent of myocardial hypoperfusion in the present study.31
Conclusions
In women and men with NSTEMI, the global coronary
artery plaque area was an important determinant of the se-
verity of myocardial hypoperfusion at rest independent of
presence of significant coronary stenoses. These findingsmay
expand current understanding of NSTEMI in patients with
nonobstructive CAD.
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